Effect of Web-Based Education on Gestational Diabetes Mellitus and Health Management Self Efficacy

Not Applicable

Completed

• Conditions: Pregnancy Complications; Efficacy, Self
• Interventions: Behavioral: web based education

• Registration Number: NCT05141929
• Lead Sponsor: Dokuz Eylul University

Brief Summary

This randomized controlled study aimed to examine the effect of web-based education related to Gestational Diabetes Mellitus on women health management self-efficacy and maternal-fetal-neonatal results.

Detailed Description

Objective: To examine the effect of web-based education related to Gestational Diabetes Mellitus on women health management self-efficacy and maternal-fetal-neonatal results.

Design: Randomized controlled study. Patients: Thirty one pregnant women were included in the intervention group and thirty four pregnant women in the control group.

Interventions: For 8 weeks, web-based education for Gestational Diabetes Mellitus was offered to pregnant women who diagnosed with Gestational Diabetes Mellitus for the first time. The data were collected before web-based education, after web-based education and postpartum between 4-12 weeks at three different times. Control group was offered routine clinical procedure.

Main Outcome Measures: health management self efficacy (primary outcomes), maternal-fetal-neonatal results (secondary outcome).

Study Timeline

• Study Start: 2020-06-01
• Primary Completion: 2021-06-01
• Study Completion: 2021-08-30
• Study First Submitted: 2021-10-25
• Study First Submitted QC: 2021-11-19
• Status Verified: 2021-12
• Study First Posted: 2021-12-02
• Last Update Submitted: 2021-12-02
• Last Update Posted: 2021-12-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 65

Inclusion Criteria

• Being 18 years or older
• Being primigravida or multigravida
• Getting a diagnosis of Gestational Diabetes Mellitus
• Having a gestational week between 24-28
• Having a single fetus
• Ability to use the Internet (Computer, tablet, smart phone, etc.)
• Voluntary participation in the research

Exclusion Criteria

• Having a diagnosis of Type 1 and Type 2 Diabetes Mellitus
• Having another chronic disease
• Having a visual or hearing impairment
• Having a psychiatric medical diagnosis
• Having a diagnosis of risky pregnancy not related to GDM

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
intervention group	web based education	web based education and routine clinical procedure

Primary Outcome Measures

Name	Time	Method
Change from Self Rated Abilities for Health Practices levels in pregnant women with GDM	Change in Self Rated Abilities for Health Practices levels up to postpartum 12th week	Self Rated Abilities for Health Practices Scale: Self Rated Abilities for Health Practices Scale: The 5-point Likert scale was adapted for Turkish version by Aypar Akbağ and Aluş Tokat (Aypar Akbağ and Aluş Tokat, 2021). The scale consists of 4 sub-dimensions: "Exercise"," Responsible Health Practices", "Psychological Well Being" and "Nutrition". (from 0 (not at all) to 4 (completely). The scale total-score ranged between 0 and 112, while subscale total-scores ranging from 0 to 28 points. The higher scores from the scale indicate higher self-efficacy levels for the health applications.

Secondary Outcome Measures

Name	Time	Method
Rate of maternal-fetal-neonatal complications in pregnant women with GDM	Change in rate of maternal, fetal and neonatal complications up to postpartum 12th week	The chart was used to evaluate the maternal (ketoacidosis, preeclampsia, polyhydramnios, preterm labor, vaginal or urinary infection), fetal (macrosomia, Intrauterine Growth Retardation) and neonatal (neonatal hypoglycemia, polycythemia and neonatal hyperbilirubinemia, duration of treatment for hyperbilirubinemia, Respiratory Distress Syndrome (RDS), hypothermia, dehydration) complications of Gestational Diabetes Mellitus. Complications during pregnancy and postpartum period were followed up. Complication follow-up was done by contacting the intervention group via the website. In the control group, complication follow-up was obtained by phone calls.

Trial Locations

Locations (1)

Dokuz Eylul University; 🇹🇷 İzmir, Turkey